This list is an analysis based on recent market events. It's not an investment recommendation.
About
Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research. The company offers PreciseInhale, a laboratory system that allows scientists to measure how inhaled particles act in lungs and affect the health; DissolvIt, which enables in vitro simulation of dissolution and absorption of respirable particles in the lung epithelium; XposeALI, a 3D cell exposure module that combines aerosol capability with 3D cell models cultured at an air liquid interface; Nose-only inhalation, a standard method of exposure used in preclinical testing of inhalation drugs, as well as for inhalation toxicity studies in rodents; and intratracheal exposure module, an unique technology delivering aerosol directly to the lungs, bypassing the nose, and to spontaneously breathing rodents. Inhalation Sciences Sweden AB (publ) was incorporated in 2004 and is headquartered in Huddinge, Sweden.
What is Inhalation Sciences Sweden AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Grey Market exchange Inhalation Sciences Sweden AB stocks are traded under the ticker INHSF.
What is Inhalation Sciences Sweden AB revenue for the last year?▼
Inhalation Sciences Sweden AB revenue for the last year amounts to 320,236.38 USD.
What is Inhalation Sciences Sweden AB net income for the last year?▼
INHSF net income for the last year is -1.07M USD.
In which sector is Inhalation Sciences Sweden AB located?▼
Inhalation Sciences Sweden AB operates in the Other sector.
When did Inhalation Sciences Sweden AB complete a stock split?▼
The last stock split for Inhalation Sciences Sweden AB was on July 9, 2021 with a ratio of 11:10.